American International Group, Inc. Black Diamond Therapeutics, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $16,963 - $41,051	-11,309 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.66 - $5.61 $2,112 - $4,454	-794 Reduced 6.56%	11,309 $31,000
Q4 2021 Feb 11, 2022	SELL	$5.18 - $8.48 $1,880 - $3,078	-363 Reduced 2.91%	12,103 $65,000
Q3 2021 Nov 12, 2021	SELL	$8.46 - $12.42 $2,504 - $3,676	-296 Reduced 2.32%	12,466 $105,000
Q2 2021 Aug 13, 2021	BUY	$12.19 - $28.17 $27,098 - $62,621	2,223 Added 21.09%	12,762 $156,000
Q1 2021 May 07, 2021	BUY	$22.23 - $34.75 $644 - $1,007	29 Added 0.28%	10,539 $256,000
Q4 2020 Feb 12, 2021	SELL	$29.47 - $35.0 $8,899 - $10,570	-302 Reduced 2.79%	10,510 $337,000
Q3 2020 Nov 04, 2020	BUY	$26.17 - $43.07 $86,230 - $141,915	3,295 Added 43.83%	10,812 $327,000
Q2 2020 Aug 12, 2020	BUY	$22.3 - $44.8 $8,340 - $16,755	374 Added 5.24%	7,517 $317,000
Q1 2020 May 04, 2020	BUY	$18.18 - $39.48 $129,859 - $282,005	7,143 New	7,143 $178,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.6M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.